Epidemiology: Glomerulonephritis Represents 10-15% of Glomerular Diseases.
Allo-Immune Membranous Nephropathy and Recombinant Arylsulfatase Replacement Therapy: A Need for Tolerance Induction Therapy Hanna Debiec, Vassili Valayannopoulos,
leziuni veziculo-buloase
0.5 mg/kg/ week
